Stem Cell Research

Article	Citations
Neutralizing antibodies targeting SARS-CoV-2 spike protein	92
Furin cleavage sites naturally occur in coronaviruses	66
Human mesenchymal stem cells promote ischemic repairment and angiogenesis of diabetic foot through exosome miRNA-21-5p	57
Haplobanking induced pluripotent stem cells for clinical use	37
Methadone interrupts neural growth and function in human cortical organoids	36
Generation of pure monocultures of human microglia-like cells from induced pluripotent stem cells	29
Exosomes from 3D culture of marrow stem cells enhances endothelial cell proliferation, migration, and angiogenesis via activation of the HMGB1/AKT pathway	26
NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells	24
Transplantation of iPSC-derived corneal endothelial substitutes in a monkey corneal edema model	23
Establishment of human induced trophoblast stem-like cells from term villous cytotrophoblasts	23
Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming	22
A safety consideration of mesenchymal stem cell therapy on COVID-19	21
CiRA iPSC seed stocks (CiRA's iPSC Stock Project)	20
Human corneal limbal organoids maintaining limbal stem cell niche function	20
The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries	20
Functional and molecular effects of TNF-α on human iPSC-derived cardiomyocytes	20
In vivo regeneration of rat laryngeal cartilage with mesenchymal stem cells derived from human induced pluripotent stem cells via neural crest cells	20
Cancer stem cell markers for liver cancer and pancreatic cancer	19
Non-permissive SARS-CoV-2 infection in human neurospheres	18
The Global Alliance for iPSC Therapies (GAiT)	18
Matrigel is required for efficient differentiation of isolated, stem cell-derived otic vesicles into inner ear organoids	18
Eyes on coronavirus	17
Sex-dependent immune response and lethality of COVID-19	17
In vitro differentiation of pluripotent stem cells into hepatocyte like cells – Basic principles and current progress	17
Generation of two gene edited iPSC-lines carrying a DOX-inducible NGN2 expression cassette with and without GFP in the AAVS1 locus	16

Generation of striatal neurons from human induced pluripotent stem cells by controlling extrinsic signals with small molecules	15
Cardiac fibrosis models using human induced pluripotent stem cell-derived cardiac tissues allow anti-fibrotic drug screening in vitro	15
Korea National Stem Cell Bank	14
Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis	14
Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery	14
Pluripotent pig embryonic stem cell lines originating from in vitro-fertilized and parthenogenetic embryos	14
Generation of an induced pluripotent stem cell line (UNCCi002-A) from a healthy donor using a non-integration system to study Cerebral Cavernous Malformation (CCM)	13
Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells	12
Quantitative analysis of mitochondrial morphologies in human induced pluripotent stem cells for Leigh syndrome	12
Self-assembling 3D spheroid cultures of human neonatal keratinocytes have enhanced regenerative properties	12
Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system	12
Generation of iPSC lines from two patients affected by febrile seizure due to inherited missense mutation in SCN1A gene	12
Adipose-derived stromal vascular fraction (SVF) cells for the treatment of non-reconstructable peripheral vascular disease in patients with critical limb ischemia: A 6-year follow-up showing durable e	12
Isolation of PRRX1-positive adult pituitary stem/progenitor cells from the marginal cell layer of the mouse anterior lobe	12
Blebbistatin protects iPSC-CMs from hypercontraction and facilitates automated patch-clamp based electrophysiological study	12
Generation of disease-specific and CRISPR/Cas9-mediated gene-corrected iPS cells from a patient with adult progeria Werner syndrome	11
Generation of two induced pluripotent stem cell lines with heterozygous and homozygous GAG deletion in TOR1A gene from a healthy hiPSC line	11
Multiomics analyses of cytokines, genes, miRNA, and regulatory networks in human mesenchymal stem cells expanded in stirred microcarrier-spinner cultures	11
Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2)	11
SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells	11
Establishment of novel common marmoset embryonic stem cell lines under various conditions	11
The EBiSC iPSC bank for disease studies	11
Polyvinyl alcohol hydrolysis rate and molecular weight influence human and murine HSC activity ex vivo	10
Modeling cancer progression using human pluripotent stem cell-derived cells and organoids	10
PI3K-Akt signaling regulates BMP2-induced osteogenic differentiation of mesenchymal stem cells (MSCs): A transcriptomic landscape analysis	10
Generation of an integration-free induced pluripotent stem cell line (UNC001-A) from blood of a healthy individual	10
Decoding molecular markers and transcriptional circuitry of naive and primed states of human pluripotency	10
Development of a fully human assay combining NGN2-inducible neurons co-cultured with iPSC-derived astrocytes amenable for electrophysiological studies	10
Control of mesenchymal cell fate via application of FGF-8b in vitro	10
LncRNA Mrhl orchestrates differentiation programs in mouse embryonic stem cells through chromatin mediated regulation	10
Electrophysiological evaluation of human induced pluripotent stem cell-derived cardiomyocytes obtained by different methods	10
Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing	10
Generation of integration-free induced pluripotent stem cells from healthy individuals	9
Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing	9
Medical progress: Stem cells as a new therapeutic strategy for COVID-19	9
Cdkn1a deletion or suppression by cyclic stretch enhance the osteogenic potential of bone marrow mesenchymal stem cell-derived cultures	9
Superoxide dismutase and catalase significantly improve the osteogenic differentiation potential of osteogenetically compromised human adipose tissue-derived stromal cells in vitro	9
Systematic assessment of variability in the proteome of iPSC derivatives	9
Non-viral derivation of a transgene-free induced pluripotent stem cell line from a male beagle dog	9
Structural insights into SARS-CoV-2 infection and therapeutics development	9
Generation of a double insulin and somatostatin reporter line, SCSe001-A-3, for the advancement of stem cell-derived pancreatic islets	9
Human-induced pluripotent stem cell lines (CMCi006-A and CMCi007-A) from a female and male patient with Fabry disease carrying the same frameshift deletion mutation	9
Reliable generation of glial enriched progenitors from human fibroblast-derived iPSCs	9
Adaptation of the AID system for stem cell and transgenic mouse research	9
Restorative effect of adipose tissue-derived stem cells on impaired hepatocytes through Notch signaling in non-alcoholic steatohepatitis mice	9
Generation and genetic repair of two human induced pluripotent cell lines from patients with Epidermolysis Bullosa simplex and dilated cardiomyopathy associated with a heterozygous mutation in the tra	9
Endothelial cell secreted VEGF-C enhances NSC VEGFR3 expression and promotes NSC survival	9
The International Stem Cell Banking Initiative (ISCBI)	8
Generation of multiple iPSC clones from a male schizophrenia patient carrying de novo mutations in genes KHSRP, LRRC7, and KIR2DL1, and his parents	8
Generation of gene-corrected isogenic control cell lines from a DYT1 dystonia patient iPSC line carrying a heterozygous GAG mutation in TOR1A gene	8

Generation of a human induced pluripotent stem cell line (CPGHi001-A) from a hearing loss patient with the TMC1 p.M418K mutation	8
Cellular reprogramming to model and study epigenetic alterations in cancer	8
ATM modulates subventricular zone neural stem cell maintenance and senescence through Notch signaling pathway	8
Generation of induced pluripotent stem cell line RCPCMi008-A derived from patient with spinocerebellar ataxia 17	8
Extracellular laminin regulates hematopoietic potential of pluripotent stem cells through integrin β1-ILK-β-catenin-JUN axis	8
Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing	8
Patient-specific iPSC-derived cellular models of LGMDR1	8
Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control	8
Generation of patient-specific induced pluripotent stem cell line (CSUi002-A) from a patient with isolated dystonia carrying TOR1A mutation	8
Generation of integration-free induced pluripotent stem cell lines from four pediatric ADHD patients	8
Modeling leukemia with pediatric acute leukemia patient-derived iPSCs	8
Distinct molecular profile and restricted stem cell potential defines the prospective human cranial neural crest from embryonic stem cell state	8
The fate of human SUSD2+ endometrial mesenchymal stem cells during decidualization	7
Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines	7
Inhibition of focal adhesion kinase increases adult olfactory stem cell self-renewal and neuroregeneration through ciliary neurotrophic factor	7
A generation of human induced pluripotent stem cell line (MUi031-A) from a type-3 Gaucher disease patient carrying homozygous mutation on GBA1 gene	7
Derivation of stem cell line UMi028-A-2 containing a CRISPR/Cas9 induced Alzheimer’s disease risk variant p.S1038C in the TTC3 gene	7
Transcription factor overexpression drives reliable differentiation of retinal pigment epithelium from human induced pluripotent stem cells	7
Mesenchymal stem cells and prostate cancer: A concise review of therapeutic potentials and biological aspects	7
Transient receptor potential vanilloid 2 mediates the inhibitory effect of far-infrared irradiation on adipogenic differentiation of tonsil-derived mesenchymal stem cells	7
Donor-derived vasculature is required to support neocortical cell grafts after stroke	7
An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects	7
Generation of a human induced pluripotent stem cell line (CMCi002-A) from a patient with Gitelman’s syndrome	7
Metabolic maturation of differentiating cardiosphere-derived cells	7
Modeling of osteosarcoma with induced pluripotent stem cells	7
Generation and characterization of iPSC lines (UOHi003-A, UOHi002-A) from a patient with SHANK3 mutation and her healthy mother	7
Generation of a human iPSC line from an epileptic encephalopathy patient with electrical status epilepticus during sleep carrying KCNA2 (p.P405L) mutation	7
Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1)	7
Establishment of two hiPSC lines (IIMCBi001-A and IIMCBi002-A) from dermal fibroblasts of healthy donors and characterization of their cell cycle	7
Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene	7
Generation of six human iPSC lines from patients with a familial Alzheimer’s disease (n = 3) and sex- and age-matched healthy controls (n = 3)	7
Establishment of KEIOi005-A iPSC line from urine-derived cells (UDCs) of a mild Alzheimer’s disease (AD) donor with multiple risk SNPs for sporadic Alzheimer’s disease (sAD)	6
Increasing cytosolic Ca2+ levels restore cell proliferation and stem cell potency in aged MSCs	6
Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants	6
Generation of clinical-grade human embryonic stem cell line KthES11 according to Japanese regulations	6
Establishment of an induced pluripotent stem cell line from a female domestic ferret (Mustela putorius furo) with an X chromosome instability	6
Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease	6
Generation of a heterozygous C-peptide-mCherry reporter human iPSC line (HMGUi001-A-8)	6
Branched-chain amino acid aminotransferase-1 regulates self-renewal and pluripotency of mouse embryonic stem cells through Ras signaling	6
Generation of an induced pluripotent stem cell line from an Alström Syndrome patient with ALMS1 mutation (c.3902C > A, c.6436C > T) and a gene correction isogenic iPSC line	6
In vitro expansion of cirrhosis derived liver epithelial cells with defined small molecules	6
Neutrophils generated in vitro from hematopoietic stem cells isolated from apheresis samples and umbilical cord blood form neutrophil extracellular traps	6
Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing	6
A kainic acid-induced seizure model in human pluripotent stem cell-derived cortical neurons for studying the role of IL-6 in the functional activity	6
Generation of an induced pluripotent stem cell line from a congenital microtia patient with 4p16.1 microduplication involving the long-range enhancer of HMX1	6
Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing	6
Generation of human iPSC line (UCLi013-A) from a patient with microphthalmia and aniridia, carrying a heterozygous missense mutation c.372C>A p.(Asn124Lys) in PAX6	6
Establishment of iPSC lines from a high-grade Klinefelter Syndrome patient (49-XXXXY) and two genetically matched healthy relatives (KAUSTi003-A, KAUSTi004-A, KAUSTi004-B, KAUSTi005-A, KAUSTi005-B, KA	6
Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation	6
Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 Deficiency Disorder (CDD)	6
Generation of a heterozygous GAPDH-Luciferase human ESC line (HVRDe008-A-1) for in vivo monitoring of stem cells and their differentiated progeny	6
Derivation of two naturally isogenic iPSC lines (KAUSTi006-A and KAUSTi006-B) from a mosaic Klinefelter Syndrome patient (47-XXY/46-XY)	6
Effect of initial seeding density on cell behavior-driven epigenetic memory and preferential lineage differentiation of human iPSCs	6
Generation of two human control iPS cell lines (UCLi016-A and UCLi017-A) from healthy donors with no known ocular conditions	6
Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy	6
Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous	6
Generation of a Friedreich’s Ataxia patient-derived iPSC line USFi001-A	5
Generation of two human iPSC lines, FINCBi002-A and FINCBi003-A, carrying heteroplasmic macrodeletion of mitochondrial DNA causing Pearson’s syndrome	5
Establishment of iPSC (KRIBBi001-A) from CD34+ group O D-negative bone marrow blood	5
Comparison of the biological and functional characteristics of mesenchymal stem cells from intrahepatic and identical bone marrow	5
Generation of a TPM1 homozygous knockout embryonic stem cell line by CRISPR/Cas9 editing	5
Generation of B2M bi-allelic knockout human induced pluripotent stem cells (MUSIi001-A-1) using a CRISPR/Cas9 system	5
Generation of an human induced pluripotent stem cell JTUi007-A from a patient with CSF1R-related leukoencephalopathy carrying heterozygous p.Ile794Thr mutation in CSF1R gene	5
Generation of iPSC line (FAMRCi009-A) from patient with familial progressive cardiac conduction disorder carrying genetic variant FLNC p.Val2264Met	5
Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s disease	5
CRISPR/Cas9 mediated establishment of a human CSRP3 compound heterozygous knockout hESC line to model cardiomyopathy and heart failure	5
Generation of a control human induced pluripotent stem cell line using the defective and persistent Sendai virus vector system	5
Generation of four iPSC lines from four patients with Leigh syndrome carrying homoplasmic mutations m.8993T > G or m.8993T > C in the mitochondrial gene MT-ATP6	5
Generation of AAVS1 and CLYBL STRAIGHT-IN v2 acceptor human iPSC lines for integrating DNA payloads	5
A quantitative hematopoietic stem cell reconstitution protocol: Accounting for recipient variability, tissue distribution and cell half-lives	5
Divergent roles for KLF4 and TFCP2L1 in naive ground state pluripotency and human primordial germ cell development	5
Ataxia Telangiectasia iPSC line generated from a patient olfactory biopsy identifies novel disease-causing mutations	5
Generation of an induced pluripotent stem cell line (IUFi001) from a Cockayne syndrome patient carrying a mutation in the ERCC6 gene	5
Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease	5
Chromatin accessibility profiling identifies evolutionary conserved loci in activated human satellite cells	5
Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation	5
Generation of a human induced pluripotent stem cell line (CPGHi003-A) from an auditory neuropathy patient with AIFM1 p.R422Q mutation	5
Establishment and characterization of induced pluripotent stem cell line (IGIBi002-A) from a β-thalassemia patient with IVS1-5 mutation by non-integrating reprogramming approach	5
Generation of human induced pluripotent stem cell lines derived from four DiGeorge syndrome patients with 22q11.2 deletion	5
Generation of induced pluripotent stem cell line, ICGi034-A, by reprogramming peripheral blood mononuclear cells from a patient with Parkinson’s disease associated with GBA mutation	5

Generation of hiPSC-derived low threshold mechanoreceptors containing axonal termini resembling bulbous sensory nerve endings and expressing Piezo1 and Piezo2	5
Generation of a homozygous knock-in human embryonic stem cell line expressing SNAP-tagged SOD1	5
Self-replicative mRNA-mediated generation of induced pluripotent stem cell line from a 1-year-old Leigh syndrome patient with mitochondrial DNA cytochrome b mutation	5
Establishment of a GFP::LMNB1 knockin cell line (CSUi002-A-1) from a dystonia patient-specific iPSC by CRISPR/Cas9 editing	5
Generation of pulmonary arterial hypertension patient-specific induced pluripotent stem cell lines from three unrelated patients with a heterozygous missense mutation in exon 12, a heterozygous in-fra	5
Generation of MNZTASi001-A, a human pluripotent stem cell line from a person with primary progressive multiple sclerosis	5
A stress-free strategy to correct point mutations in patient iPS cells	5
Generation of two induced pluripotent stem cell (iPSC) lines (BBANTWi006-A, BBANTWi007-A) from Brugada syndrome patients carrying an SCN5A mutation	5
Derivation of iPSC line (RCMGi002-A) from dermal fibroblasts of a cystic fibrosis female patient with homozygous F508del mutation	5
Generation of three human iPSC lines from patients with a spontaneous late-onset Alzheimer’s disease and three sex- and age-matched healthy controls	5
A critical review on induced totipotent stem cells: Types and methods	5
Peripheral sensory neurons promote angiogenesis in neurovascular models derived from hESCs	5
Generation of induced pluripotent stem cell GZLSL-i001-A derived from urine-derived cells of Hemophilia A patient with Inv22 mutation	5
Establishment of MHHi001-A-5, a GCaMP6f and RedStar dual reporter human iPSC line for in vitro and in vivo characterization and in situ tracing of iPSC derivatives	5
Generation of human iPSC line from an arrhythmogenic cardiomyopathy patient with a DSP protein-truncating variant	5
Generation and characterisation of four multiple sclerosis iPSC lines from a single family	5
Generation of two induced pluripotent stem cell lines (RCMGi004-A and -B) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/W1282X mutations in CFTR gene	5
Transporting ESCs in FBS at ambient temperature	4
Generation of patient-derived IPSC lines from a girl with Combined Oxidative Phosphorylation Deficiency 23 (COXPD23) caused by compound heterozygous GTPBP3 variants	4
Status epilepticus induced Gadd45b is required for augmented dentate neurogenesis	4
Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donor	4
Generation of nine iPSC lines (HNMUi002-A, HNMUi003-A, HNMUi004-A, HNMUi005-A, HNMUi006-A, HNMUi007-A, HNMUi008-A, HNMUi009-A, HNMUi010-A) from three Chinese families with thalassemia	4
Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9	4
Generation of induced pluripotent stem cells from three individuals with Huntington‘s disease	4
Generation of two human NRF2 knockout iPSC clones using CRISPR/Cas9 editing	4
Generation of an iPSC line (AKOSi006-A) from fibroblasts of an NPC1 patient, carrying the homozygous mutation p.I1061T (c.3182 T > C) and a control iPSC line (AKOSi007-A) using a non-integrating Se	4
Establishment of a novel human iPSC line (SDQLCHi032-A) derived from a patient with primary hypertrophic osteoarthropathy caused by HPGD homozygous mutation	4
Generation of four severe early-onset chronic obstructive pulmonary disease (COPD) patient-derived induced pluripotent stem cell lines from peripheral blood mononuclear cells	4
Generation of a CRISPR/Cas edited human induced pluripotent stem cell line DHMi005-A-1 carrying a patient-specific disease-causing point mutation in the TBX5 gene	4
An induced pluripotent stem cell line (GZHMCi003-A) derived from a fetus with exon 3 heterozygous deletion in RUNX2 gene causing cleidocranial dysplasia	4
Generation of an iPSC line (UNINAi001-A) from a girl with neonatal-onset epilepsy and non-syndromic intellectual disability carrying the homozygous KCNQ3 p.PHE534ILEfs*15 variant and of an iPSC line (	4
Generation and characterization of human induced pluripotent stem cells (iPSCs) from three patients with age-related macular degeneration carrying rare variants in the CFH gene	4
Abnormal DNA methylation in pluripotent stem cells from a patient with Prader-Willi syndrome results in neuronal differentiation defects	4
Hypoxia depletes contaminating CD45+ hematopoietic cells from murine bone marrow stromal cell (BMSC) cultures: Methods for BMSC culture purification	4
Generation of two isogenic induced pluripotent stem cell lines from a 4-month-old severe nemaline myopathy patient with a heterozygous dominant c.553C > A (p.Arg183Ser) variant in the ACTA1 gene	4
The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system	4
Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system	4
Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient	4
Establishment of patient-specific induced pluripotent stem cell line SDUBMSi009-A from a patient with X-linked Lowe syndrome	4
Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency	4
Generation of a FTO gene knockout human embryonic stem cell line using CRISPR/Cas9 editing	4
Induced pluripotent stem cell line ICGi036-A generated by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia caused due to compound heterozygous p.Ser17	4
Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome	4
Generation of a common marmoset embryonic stem cell line CMES40-OC harboring a POU5F1 (OCT4)-2A-mCerulean3 knock-in reporter allele	4
Establishment of an induced pluripotent stem (iPS) cell line (SDUKIi006-A) from a 21-year old male patient diagnosed with atypical autism disorder	4
Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson’s disease carrying the I2020T mutation in LRRK2	4
Hypertonic pressure affects the pluripotency and self-renewal of mouse embryonic stem cells	4
Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene	4
Generation of R272Q, S156A and K572R RHOT1/Miro1 point mutations in iPSCs from a healthy individual using FACS-assisted CRISPR/Cas9 genome editing	4
Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation	4
Induced pluripotent stem cells and hematological malignancies: A powerful tool for disease modeling and drug development	4
Restoring vision and rebuilding the retina by Müller glial cell reprogramming	4
Generation of two induced pluripotent stem cell lines from blood cells of a prostate cancer patient carrying germline mutation in CHEK2	4
Generation of the CRISPR/Cas9-mediated KIF1C knock-out human iPSC line HIHRSi003-A-1	4
Generation and characterization of three human induced pluripotent stem cell lines (iPSC) from two family members with dilated cardiomyopathy and left ventricular noncompaction (DCM-LVNC) and one heal	4
Generation of two human induced pluripotent stem cell lines derived from two X-linked adrenoleukodystrophy patients with ABCD1 mutations	4
Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation	4
Generation of induced pluripotent stem cell (iPSC) lines from a Joubert syndrome patient with compound heterozygous mutations in C5orf42 gene	4
p53 coordinates glucose and choline metabolism during the mesendoderm differentiation of human embryonic stem cells	4
Generation of human induced pluripotent stem cell lines from 2 patients with MIRAGE syndrome	4
Generation of six human induced pluripotent stem cell sublines (MZT01E, MZT01F, MZT01N and MZT02D, MZT02G and MZT02H) for reproductive science research	4
Human iPSC lines from a Christianson syndrome patient with NHE6 W523X mutation, a biologically-related control, and CRISPR/Cas9 gene-corrected isogenic controls	4
Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parent	4
Repair of acute liver damage with immune evasive hESC derived hepato-blasts	4
Reprogramming of a human induced pluripotent stem cell (iPSC) line from a patient with neurodegeneration with brain iron accumulation (NBIA) harboring a novel frameshift mutation in C19orf12 gene	4
Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis	4
Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing	4
A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy	4
Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1	4
CD200 -dependent and -independent immune-modulatory functions of neural stem cells	4
Human iPSC-derived neural crest stem cells can produce EPO and induce erythropoiesis in anemic mice	4
Generation of AAVS1 integrated doxycycline-inducible CRISPR-Prime Editor human induced pluripotent stem cell line	4
Generation of integration free hiPSCs clones, NSi001-A, NSi001-B, and NSi001-C from peripheral blood mononuclear cells of an individual with down syndrome having Robertsonian translocation	4
Establishment of a Vietnamese ethnicity induced pluripotent stem cell line (VRISGi001-A) from umbilical cord blood hematopoietic stem cells under a feeder-free system	4
Developmental deficits and early signs of neurodegeneration revealed by PD patient derived dopamine neurons	4
Generation of a human induced pluripotent stem cell line from a Bietti crystalline corneoretinal dystrophy patient with CYP4V2 mutations	4
Generation of human induced pluripotent stem cell (hiPSC) line UOMi005-A from PBMCs of a patient with Kearns-Sayre syndrome	4
Generation of induced pluripotent stem cells (NIMHi004-A, NIMHi005-A and NIMHi006-A) from healthy individuals of Indian ethnicity with no mutation for Parkinson’s disease related genes	4
UK Stem Cell Bank	4
Enhancement of airway epithelial cell differentiation by pulmonary endothelial cell co-culture	4
Isolation and characterization of bone marrow-derived mesenchymal stem cells in Xenopus laevis	4
Induced pluripotent stem cell models of myeloid malignancies and clonal evolution	4
Establishment of human induced pluripotent stem cell line (SDQLCHi040-A) from a patient with Infantile-onset inflammatory bowel disease carrying a homozygous mutation in IL10RA gene	4
Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family members	4
Generation of an NANS homozygous knockout human induced pluripotent stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9 editing	4
Src-Yap1 signaling axis controls the trophectoderm and epiblast lineage differentiation in mouse embryonic stem cells	4
Generation of an iPSC line (CRICKi001-A) from an individual with a germline SMARCA4 missense mutation and autism spectrum disorder	4
Generation of a doxycycline-inducible ETV2 expression cell line using PiggyBac transposase system	4
Establishment of a human MYH6 compound heterozygous knockout hESC line to model cardiomyopathy and congenital heart defects by CRISPR/Cas9 system	4
Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA)	4
Pig embryonic stem cell line with porcine-specific OCT4 upstream region based dual reporter system	4
Generation of induced pluripotent stem cell Line KAIMRCi001-A by reprogramming erythroid progenitors from peripheral blood of a healthy Saudi donor	4
Episomal vector reprogramming of human umbilical cord blood natural killer cells to an induced pluripotent stem cell line MUSIi013-A	4
Generation of 2 isogenic clones from a patient with Trisomy 21 and a GATA1 mutation	4
Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line (CSUXHi005-A) from human urine epithelial cells	4